Aptorum Group Ltd Stock One Year Return
| APM Stock | USD 0.85 0.20 30.77% |
Aptorum Group Ltd fundamentals help investors to digest information that contributes to Aptorum Group's financial success or failures. It also enables traders to predict the movement of Aptorum Stock. The fundamental analysis module provides a way to measure Aptorum Group's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aptorum Group stock.
Aptorum | One Year Return |
Aptorum Group Ltd Company One Year Return Analysis
Aptorum Group's One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading.
More About One Year Return | All Equity Analysis
One Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Aptorum One Year Return Driver Correlations
Understanding the fundamental principles of building solid financial models for Aptorum Group is extremely important. It helps to project a fair market value of Aptorum Stock properly, considering its historical fundamentals such as One Year Return. Since Aptorum Group's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Aptorum Group's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Aptorum Group's interrelated accounts and indicators.
Click cells to compare fundamentals
Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.
| Competition |
Aptorum Return On Tangible Assets
Return On Tangible Assets |
|
Based on the recorded statements, Aptorum Group Ltd has an One Year Return of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Aptorum One Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aptorum Group's direct or indirect competition against its One Year Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aptorum Group could also be used in its relative valuation, which is a method of valuing Aptorum Group by comparing valuation metrics of similar companies.Aptorum Group is currently under evaluation in one year return category among its peers.
Aptorum Fundamentals
| Return On Equity | -0.37 | ||||
| Return On Asset | -0.32 | ||||
| Operating Margin | (24.86) % | ||||
| Current Valuation | 4.92 M | ||||
| Shares Outstanding | 3.81 M | ||||
| Shares Owned By Insiders | 23.71 % | ||||
| Shares Owned By Institutions | 1.45 % | ||||
| Number Of Shares Shorted | 13.12 K | ||||
| Price To Earning | 2.70 X | ||||
| Price To Book | 0.15 X | ||||
| Price To Sales | 10.99 X | ||||
| Revenue | 431.38 K | ||||
| Gross Profit | 81.85 K | ||||
| EBITDA | (9.6 M) | ||||
| Net Income | (4.34 M) | ||||
| Cash And Equivalents | 4.22 M | ||||
| Cash Per Share | 0.12 X | ||||
| Total Debt | 3.28 M | ||||
| Debt To Equity | 0.23 % | ||||
| Current Ratio | 1.14 X | ||||
| Book Value Per Share | 4.79 X | ||||
| Cash Flow From Operations | (7.72 M) | ||||
| Short Ratio | 0.39 X | ||||
| Earnings Per Share | (0.62) X | ||||
| Target Price | 80.0 | ||||
| Beta | 1.3 | ||||
| Market Capitalization | 4.74 M | ||||
| Total Asset | 20.64 M | ||||
| Retained Earnings | (68.16 M) | ||||
| Working Capital | 377.34 K | ||||
| Current Asset | 25.7 M | ||||
| Current Liabilities | 10.9 M | ||||
| Net Asset | 20.64 M |
About Aptorum Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aptorum Group Ltd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aptorum Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aptorum Group Ltd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Aptorum Group Piotroski F Score and Aptorum Group Altman Z Score analysis. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aptorum Group. If investors know Aptorum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aptorum Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.62) | Revenue Per Share 0.095 | Quarterly Revenue Growth (1.00) | Return On Assets (0.32) | Return On Equity (0.37) |
The market value of Aptorum Group is measured differently than its book value, which is the value of Aptorum that is recorded on the company's balance sheet. Investors also form their own opinion of Aptorum Group's value that differs from its market value or its book value, called intrinsic value, which is Aptorum Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptorum Group's market value can be influenced by many factors that don't directly affect Aptorum Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aptorum Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptorum Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptorum Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.